Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments

Oritavancin is a long-acting lipoglycopeptide with in vitro activity against Gram-positive pathogens, as well as good bactericidal activity and sterilisation ability in biofilm. It has been approved for acute bacterial skin and skin structure infections (ABSSSI), but recent reports have demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupia, Tommaso, De Benedetto, Ilaria, Bosio, Roberta, Shbaklo, Nour, De Rosa, Francesco Giuseppe, Corcione, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143027/
https://www.ncbi.nlm.nih.gov/pubmed/37109488
http://dx.doi.org/10.3390/life13040959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143027/
https://www.ncbi.nlm.nih.gov/pubmed/37109488
http://dx.doi.org/10.3390/life13040959

Ejemplares similares